Neurotransmitters are thought to be released as quanta, where synaptic vesicles deliver packets of neurotransmitter to the synaptic cleft by fusion with the plasma membrane. However, synaptic vesicles may undergo incomplete fusion. We provide evidence that G protein-coupled receptors inhibit release by causing such incomplete fusion. 5-hydroxytryptamine ( 
G
protein-coupled receptor (GPCR)-mediated presynaptic inhibition is widespread, although the underlying mechanisms are not always clearly understood. Activation of a presynaptic 5-hydroxytryptamine (5-HT) GPCR nearly abolishes glutamate release from lamprey reticulospinal synapses (1) independently of presynaptic calcium (2, 3) . Calcium channel independent modulation by GPCRs, first shown at the neuromuscular junction (4), has been described since at other synapses (5) (6) (7) (8) . At the lamprey synapse, 5-HT inhibition is mediated by G␤␥ (2, 3) that binds to SNAP-25 in SNARE complexes (9) .
Neurotransmitters are widely thought to be released as vesicular quanta (10, 11) , whereby all vesicles contain equal amounts of transmitter, and their entire contents are liberated into the synapse at fixed rates. However, partial fusion events (kiss and run) that might alter neurotransmitter release have been proposed. In neuroendocrine cells, large dense-core vesicles can transiently fuse with the membrane (12) to vary release (13, 14) an effect that may be caused by G␤␥ (15) . Synaptic vesicles may also partially fuse (16) (17) (18) (19) (20) . Similarly, FM dye fluorescence measurements (21) (22) (23) (24) (25) demonstrate that vesicles fusing with the presynaptic membrane may subsequently withdraw without complete loss of fluorophorelabeled lipid.
We have demonstrated that GPCR activation leads to G␤␥ binding to the C-terminal of SNAP-25 in the SNARE complex (2, 9, 26) at a site coincident with synaptotagmin-SNARE complex binding. Modification of synaptotagmin-SNARE complex interactions can cause incomplete fusion of dense core vesicles (27, 28) , which may modify neurotransmitter release (17) . 5-HT-mediated inhibition at the lamprey giant synapse is blocked by presynaptic injection of a G␤␥ scavenger (C terminus of G protein receptor kinase 2; ref. 2) . Similarly, 5-HT no longer inhibits neurotransmitter release after presynaptic injection of botulinum toxin A, which cleaves the nine most C-terminal residues of SNAP-25, nor after presynaptic injection of a peptide corresponding to the C-terminal 14 amino acids of SNAP-25 (9, 26) . We now demonstrate that this presynaptic 5-HT GPCR reduces the quantal amplitude of excitatory postsynaptic currents (EPSCs). Unitary EPSC recording and staining of synaptic vesicles with FM dyes demonstrate that this effect can be explained by a change in vesicle fusion properties.
Results

5-HT Reduces Evoked Unitary Quantal
Amplitude of EPSCs. 5-HT inhibits release by acting through G␤␥ on the SNARE complex (2, 9) . In PC12 cells, G␤␥ also inhibits release at the SNARE complex (26) and modulates quantal size (15) . To investigate whether 5-HT reduces the amplitude or number of quanta underlying EPSCs, we chose a dose of 5-HT close to the EC 50 (600 nM) (29) that inhibited EPSCs but left sufficient response to investigate its effect on quantal amplitudes. The mean EPSC amplitude was reduced by 5-HT (to 51 Ϯ 9% of control, n ϭ 10 pairs). In five pairs, the release probability was sufficiently low to separate statistically the unitary response from recording noise (Fig. 1) . At least 200 stimuli were applied before (Fig. 1 A) and 200 in 5-HT (Fig. 1B) . Whole cell access was simultaneously monitored (Fig. 1C) . EPSC amplitude plots reveal that separation between failures and the lowest quantal amplitude, which remained constant throughout the control recording, was lost in 5-HT (Fig. 1D ), even while a significant fraction (Ϸ50%) of the EPSC was retained. Fig. 1 E and F shows amplitude data (Fig. 1D ) binned into histograms. The smooth curves centered at the 0 pA amplitude bin are single Gaussians fitted to the recording noise, demonstrating no difference between failures and noise. In all five recordings for the control amplitude distributions, a significant separation is seen between failures and unitary events. This separation is also apparent in Fig. 1D , where the region between 0 and -5pA is clear of responses throughout the control recording. Multiple Gaussian curves were fitted to the evoked EPSCs in the control histograms ( Fig. 1E; ref. 10; Materials and Methods). In contrast, in 5-HT, no statistically separate failures and unitary events were distinguished (n ϭ 5). It was not possible to fit any combination of Gaussians to the histogram data in 5-HT in any of the five pairs (Fig. 6 , which is published as supporting information on the PNAS web site). Results from all five pairs were pooled by normalizing the amplitude data to the unitary amplitude. The five histograms in control and 5-HT were averaged. The trough in amplitudes between failures and responses was compared to data obtained in 5-HT, where a significantly larger numbers of events were recorded ( Fig. 1 G and H) . These results represent either a decrease in the postsynaptic response to transmitter release (10) or a decrease in cleft transmitter concentration. However, the effect of 5-HT is mediated entirely by a presynaptic effect of G␤␥ at the SNARE complex (2, 9, 26) .
This analysis allowed us to directly investigate changes in quantal size, but was not always possible, because the failure rate was too low to observe a unitary quantal amplitude. An alternative analysis of less ideal data sets was explored (30) , in which the mean amplitude of the response and its variance was compared (31) . The relationship mean 2 ͞variance (M 2 ͞ 2 ) varies linearly or supralinearly with mean EPSC amplitude when release probability is altered but is invariant when the amplitude of each release event is altered if recording noise does not significantly impact the recorded variance.
We calculated M 2 ͞ 2 for another five pairs in which the failure rate was insufficient to measure quantal amplitude directly. This alternate analysis allows us to independently assess results in Fig. 1 . We excluded synapses with a high failure rate from this analysis (five pairs in Fig. 1 ). We also excluded EPSCs whose amplitude histograms were skewed to an invariant high release probability and some noisy recordings where EPSCs could not be separated from recording noise. These exclusions ensured that recording noise did not dominate the recorded variance. Thus, in the example (Fig. 2  A-C) , variance of the control recording noise was 4 pA 2 , and variance of the control EPSC amplitude was 1,302 pA 2 . In 5-HT, variance of the recording noise was 3 pA 2 , and variance of the EPSC amplitude was 399 pA 2 (Fig. 2C) . The recording noise represented an insignificant fraction of the recorded EPSC variance. Electrical components of the EPSCs were unaffected by 5-HT ( Fig. 2 A and C; variance of the peak of the electrical component was not significantly different from recording noise; P Ͻ 0.05). The electrical component confirmed action potential invasion of the presynaptic terminal (32) and acted as a control to ensure no postsynaptic dendritic modification of the EPSC occurred. 5-HT (600 nM) partially inhibited the EPSC (Fig. 2 A-C (34) . None of these conditions apply in our study. All analyses were performed in paired recordings, markedly narrowing the variability of the synaptic pool. Monitoring the EPSC electrical component ensured that presynaptic action potentials always invaded the terminal ( Fig. 2 A and C) , and prior data comparing number of release sites to synaptic responses implies a release probability of Ϸ0.3 (3). Finally, dendritic modification did not contribute because the EPSC electrical component was unaffected by 5-HT or Mg 2ϩ . Thus, although not conclusive on their own, these data are supportive of our results in Fig. 1 .
5-HT Inhibits Stimulus-Evoked FM Dye Uptake Similarly to Its Effect on
EPSCs. We conclude that 5-HT-mediated inhibition of EPSCs results from a reduction in cleft glutamate concentration. 5-HT has no effect on postsynaptic responses to glutamate (Fig. 7A , which is published as supporting information on the PNAS web site). Reduction in cleft glutamate may follow changes in vesicle fusion, vesicle glutamate concentration, or glutamate buffering in the cleft. However, 5-HT receptor activation and G␤␥ target the vesicle fusion SNARE complex in Ͻ20 ms (9, 26) , and G␤␥ may alter fusion pore properties in PC12 cells (15) . Thus, we hypothesized that 5-HT, acting through G␤␥ at the SNARE complex, altered vesicle fusion. Accordingly, we examined synaptic vesicle cycling properties with FM dyes (35) .
Synaptic vesicles stained with FM1-43 may remain intact and not destain after transient fusion (24, 36) . Because we hypothesize that G␤␥ inhibits release late in vesicle fusion, we wished to determine whether 5-HT could disrupt FM1-43 staining and destaining of FM1-43-labeled vesicles. Synaptic vesicle clusters in single giant axons were labeled with FM1-43 by stimulation at 1 Hz (1,000 action potentials) through the recording microelectrode while FM1-43 was perfused over the spinal cord (Fig. 3A) . A small number of stimuli was chosen to allow fusion of approximately the readily releasable pool (9) to improve chances of completely destaining the labeled pool. FM1-43 perfusion was stopped, and excess dye was removed with Advasep 7 (1 mM, Ϸ1 min; ref. 37). After loading, vesicle clusters remain labeled (Fig. 3Ba) . We have previously shown that this protocol specifically labels synaptic vesicle clusters and that the fluorescence is significantly higher than background autofluorescence (38) .
Labeled axons were destained by further stimulation. A further 2,000 action potentials were applied to the axons to reduce staining to 0 Ϯ 1% of control. When the axons were relabeled with FM1-43, but in a dose of 5-HT sufficient to maximally inhibit EPSCs (30 M), staining was inhibited ( Fig. 3 Bb and Bc; 18 Ϯ 6% of control). The experiment was repeated, but after destaining the axon, only 600 nM 5-HT was included during restaining. This dose inhibits the EPSC to 50% of control ( Figs. 1 and 2 ). In this staining protocol, labeling is reduced from the control similarly to the effect of the same dose of 5-HT on EPSCs (Fig. 3 Cb and Cc; to 60 Ϯ 12% of control). When the FM1-43 is mainly in the aqueous phase (extracellular solution in the synaptic cleft), its loading into synaptic After clearing the tissue of extracellular dye, 5,000 stimuli reduced fluorescence to 9.6 Ϯ 4.1% of prestimulus intensity (n ϭ 9; Fig. 4 A and C; we define this reduction of fluorescence as control destaining). However, destaining was nearly abolished by using the same protocol in 600 nM 5-HT (Fig. 4 B and C; after 5,000 stimuli fluorescence remained at 89 Ϯ 10% of prestimulus intensity; n ϭ 5). Thus, in 600 nM 5-HT, we recorded only 15 Ϯ 10% of destaining in controls. We included a control to monitor the effect of reducing vesicle fusion probability on FM1-43 destaining. Increasing Mg 2ϩ concentrations immediately reduces vesicle fusion probability by inhibiting Ca 2ϩ entry. This reduction of probability reduced the mean EPSC amplitude (Fig. 4Db) but did not change the vesicle fusion mode. Destaining of FM1-43 in 4 mM Mg 2ϩ after 5,000 stimuli was inhibited to 46.5 Ϯ 5.4% of the prestimulus intensity (Fig. 4C) .
We compared the effects of 5-HT and Mg 2ϩ on EPSCs (Fig. 4D ) and on destaining. Bar graphs comparing the effect of 5-HT on FM1-43 destaining and on inhibition of the mean EPSC amplitude are shown (Fig. 4E) . 5-HT (600 nM) reduced the mean EPSC amplitude to 45 Ϯ 7% (n ϭ 22) of control and reduced FM1-43 destaining to 15 Ϯ 10% of control destaining ( Fig. 4Ea ; n ϭ 5). Mg 2ϩ (4 mM) reduced the EPSC to 65 Ϯ 7% of control (n ϭ 3; Fig.  4Eb ) and FM1-43 destaining to 56 Ϯ 7% of control (n ϭ 8; Fig. 4 
C and Eb).
Each destaining data set was compared to the others (two-factor ANOVA), comparing the fluorescence at each stimulus number with the equivalent in control conditions. For FM1-43, the effects of Mg 2ϩ and 5-HT were significantly different from each other and control (P Ͻ 0.05). 5-HT (600 nM; reduced EPSCs to Ϸ50% of control) largely blocked vesicle destaining. In contrast, reduced vesicle release probability (high Mg 2ϩ ) reduced EPSC amplitudes and FM1-43 destaining similarly. Because individual vesicle fusion events are unaltered in high Mg 2ϩ , there are simply fewer events, both the mean EPSC amplitude and destaining should be reduced proportionately. In 5-HT, a very different effect on destaining is seen. Although a significant EPSC is recorded, destaining is prevented. This destaining is not proportional with the effect of 5-HT on EPSC amplitudes.
We propose that 5-HT liberates G␤␥ to interact with the SNARE complex (2, 9, 26) to cause transient fusion. During this incomplete fusion, glutamate can escape from vesicles, because glutamate dissolved in the vesicle interior can escape a transiently formed pore, but the lipophilic FM1-43 cannot (28). If our hypothesis is true, then the vesicle interior must contact the extracellular space to allow glutamate release.
Continuing this line of reasoning, water-soluble molecules in the extracellular space (e.g., sulforhodamine, Fig. 5A ) should permeate the fusion pore. Sulforhodamine quenches FM1-43 by fluorescence resonance energy transfer and has been used to reduce nonsynaptic fluorescence in FM1-43-labeled hippocampal cultures (39) . Excitation with a 488-nm laser will not directly excite sulforhodamine (Fig. 5C) . The dye is a small molecule (molecular mass 560 Da), therefore, it may have access to synaptic vesicle pores even if vesicles undergo incomplete fusion in 5-HT. Sulforhodamine is highly water-soluble and should not have access to axon interiors when applied extracellularly. To confirm this inaccessibility, we superfused the tissue with sulforhodamine ( Fig. 5A ; 25 M; two spinal cords), imaged the tissue confocally, and reconstructed the volumes. An axon was filled with fluorescently labeled phalloidin (phalloidin Alexa 488) to mark its synapses. Clearly, the dye was restricted to the extracellular space. Background fluorescence in the axon interiors was unaltered by sulforhodamine. We confirmed that sulforhodamine neither altered EPSCs, nor prevented 5-HTmediated inhibition. In paired recordings (n ϭ 3; Fig. 5B ), sulforhodamine (25 M) caused no change in EPSCs (102.3 Ϯ 7.9% of control) and 5-HT (10 M) inhibited EPSCs similarly to controls (15.8 Ϯ 5.1% of control).
We tested whether vesicles stained with FM1-43 showed a stimulus-evoked reduction in FM1-43 fluorescence in 5-HT and sulforhodamine. Vesicles were labeled with FM1-43. Superfusate containing 600 nM 5-HT and 25 M sulforhodamine was added. This reduced background fluorescence such that only the labeled vesicle clusters were visible above the noise of the confocal photomultiplier tube detectors. Destaining was then monitored during stimulation. During stimulation, FM1-43 fluorescence of labeled puncta (505-560 nm) was significantly reduced (Fig. 5 D and E) in contrast with the effect of 5-HT destaining with no sulforhodamine (Fig. 4 ; also for comparison in Fig. 5E ). Destaining of FM1-43 in 600 nM 5-HT alone was blocked (89 Ϯ 10% of fluorescence remaining after 5,000 stimuli compared to 20 Ϯ 12% in 600 nM 5-HT and 25 M sulforhodamine, n ϭ 9; P Ͻ 0.01). We conclude that FM1-43 remains largely trapped in synaptic vesicles undergoing transient fusion (Fig. 4) . Sulforhodamine, however, gains access to the vesicles by diffusion through an aqueous fusion pore, leading to almost complete quenching of vesicle fluorescence of Ͼ5,000 stimuli (Fig. 5 C and E) . That sulforhodamine causes apparent destaining similar to that seen with no 5-HT present implies that 5-HT (600 nM) does not alter vesicle fusion probability because an equal number of vesicles contact the membrane in 5-HT as in controls. This contact allows sulforhodamine to enter the same number of vesicles from which FM1-43 would have escaped in controls and to effect a similar reduction in fluorescence.
Discussion
Transient vesicle fusion may represent an important component of synaptic regulation, but a controlled change of fusion mode requires a molecular mechanism. GPCRs can inhibit synaptic transmission by a direct action of G␤␥ at the SNARE complex (2, 9, 26) . We now conclude that this pathway causes transient fusion of synaptic vesicles, resulting in reduced EPSC amplitudes.
Cleavage of the presynaptic G␤␥ target blocks the effect of 5-HT entirely (2, 9) . This result, together with data showing no postsynaptic effect of 5-HT, leaves a presynaptic locus by which 5-HT alters the EPSC quantal amplitude. 5-HT, at a dose that reduces quantal size (Figs. 1 and 2) , mediates a profoundly different effect on FM1-43 destaining. This difference is explained if 5-HT causes the vesicle to fuse transiently and then withdraw from the membrane without full collapse (23, 24, 28, 40) . Thus, although 5-HT inhibits neurotransmitter release, it inhibits only to the extent that a fusion pore restricts glutamate access to the synaptic cleft. Destaining, during which FM1-43 is mostly lipid bound in the synaptic vesicle, is, in contrast, prevented by the same dose of 5-HT. If the vesicle forms a pore and then withdraws from the terminal membrane, the FM dye will remain largely trapped and will not fully destain (28) . If our hypothesis is correct, then to allow the release of some glutamate, vesicles must transiently fuse with the presynaptic membrane, which will expose the vesicle interior to the extracellular space. The stimulation-dependent quenching of FM1-43-stained vesicles with extracellular sulforhodamine strongly supports this hypothesis.
We conclude that 5-HT, acting via G␤␥ (2) at the SNARE complex (9, 26) , alters synaptic transmission to a mode in which vesicles transiently meet the plasma membrane but allow neurotransmitters to exit or sulforhodamine to enter. G␤␥ binds SNAP-25 at its C terminus in the SNARE complex and can compete with synaptotagmin for binding (9, 26) . Manipulations of synaptotagmin also alter fusion properties (27, 41, 42) . It is tempting to speculate that fusion pore stability might be modulated by signaling at the synaptotagmin-SNARE complex interface. This hypothesis is supported by our data with FM dyes to analyze synaptic vesicle fusion in 5-HT. During lipid-lipid interactions between the vesicle and the plasma membrane, which has been thought to underlie kiss-and-run fusion, FM dyes rapidly diffuse in the membrane (43) . Recording EPSCs while destaining is blocked implies that this fusion does not involve continuity between the vesicle lipid and plasma membrane. A more likely scenario is that the SNARE complex forms a channel-like protein pore (42) in which alterations in synaptotagmin interaction (9, 26) favors temporary pore formation (27, 41, 42) .
We propose that G␤␥ changes the transmitter cleft concentration by altering vesicle fusion (Fig. 5 F and G) . However, this mechanism is not the only one by which G proteins alter release. Regulation of Ca 2ϩ channels is also important at the presynaptic terminal (44, 45) . Perhaps G␤␥ acts through parallel pathways, causing reduced Ca 
Methods
Experiments were performed on larval lampreys (Petromyzon marinus) anesthetized with tricaine methanesulfonate (MS-222; 100 mg͞liter; Sigma), decapitated, and dissected in cold saline: 100 mM NaCl͞2.1 mM KCl͞2.6 mM CaCl 2 ͞1.8 mM MgCl 2 ͞4 mM glucose͞5 mM Hepes, adjusted to pH 7.6 with NaOH.
Electrophysiology. Axons were recorded with microelectrodes (1-3 M KCl; 20-50 M⍀), neurons with patch electrodes containing 102.5 mM Cs methane sulfonate, 1 mM NaCl, 1 mM MgCl 2 , 5 mM EGTA, and 5 mM Hepes, pH adjusted to 7.2 with CsOH. EPSC amplitudes measured were the difference between the current immediately before the stimulus and at the EPSC peak. Noise was the amplitude difference between data points with the same time difference but no stimulus. Whole cell access was monitored by voltage step application (Fig. 1C) .
Imaging. FM1-43 (4 M) was applied over the spinal cord while an axon was intracellularly stimulated. Postsynaptic activity was blocked with glutamate receptor antagonists CNQX and AP5 (5 and 100 M, respectively). Excess dye was removed with Advasep 7 (1 mM; ref. 37 and 38; 1 min) to reveal stimulus-dependent staining. Dye-stained axons were imaged confocally (modified Bio-Rad MRC 600) or conventionally (Hamamatsu chargecoupled device). Staining is Ca 2ϩ -dependent (37) and synapsespecific (38) . Stimulation through the recording electrode was used to probe for exocytosis-dependent destaining.
Quantal Analysis. Multiple Gaussian curves were fitted to amplitudes in control histograms (Fig. 1D) where the fit parameters were: width, A, B, C. . . , and F, G, H, . . . . All histograms from the five pairs were well fit with peak amplitudes that were multiples of the unitary amplitude. The mean peak amplitude of the smallest of these Gaussians and the mean width were significantly different from the mean amplitude of recording noise and its fitted width. In all cases, the peak current of each subsequent Gaussian (parameters F, G, H,. . . ) never deviated Ͼ10% from a multiple of the minimum peak current for the first three curves. This uniformity would be expected from a distribution of events from sums of 0, 1, and 2 quanta for each stimulus. Goodness of fit were confirmed with Kolmogoroff-Smirnoff tests for each pair (Supporting Text, which is published as supporting information on the PNAS web site) where p equals release probability of N quanta available, v equals content of each vesicle, and z the response to a unit release of transmitter. M 2 ͞ 2 is independent of z if z or the unit release remains unchanged and increases proportionately to N and linearly to p. This prediction has been experimentally confirmed at the neuromuscular junction where the quantal coefficient of variation (CV) is low. It is less clear in the CNS, where CV is likely to be high (ref. 34 ; CV at the lamprey synapse is high, 0.5 Ϯ 0.1; n ϭ 4). Nevertheless, this measure predicts a presynaptic locus with changes in presynaptic Ca 2ϩ entry, and a postsynaptic locus after postsynaptic receptor blockade.
Significance was determined by using Student's paired t test or ANOVA. P values Ͼ0.05 were determined to be not significant.
